Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Alto Neuroscience Inc. (NYSE : ANRO) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment options. Through our AI-enabled biomarker platform, we combine rich sources of information on patients¿ brain activity and behavior to better identify which patients are more likely to respond to our novel product candidates.
Quote
| Last: | $18.57 |
|---|---|
| Change Percent: | -3.98% |
| Open: | $19.8 |
| Close: | $19.34 |
| High: | $20.21 |
| Low: | $18.315 |
| Volume: | 244,417 |
| Last Trade Date Time: | 06/05/2026 01:37:15 pm |
Stock Data
| Market Cap: | $517,254,478 |
|---|---|
| Float: | 24,899,668 |
| Insiders Ownership: | 0.01% |
| Institutions: | 20 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.altoneuroscience.com |
| Country: | US |
| City: | Mountain View |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Alto Neuroscience Inc. (NYSE: ANRO).
